definiens: means the Patent Rights Controlledby [COMPANY] or its Affiliates on the Execution Date or at any time during the Term that claim thesynthesis or analysis of an oligonucleotide, including the Compound or the Product, regardlessof sequence or chemical modification ; except [COMPANY] Manufacturing Patent Rights do not includePatent Rights ( a ) specifically directed to oligonucleotide compounds that specifically modulateexpression of ANGPTL3 via the binding, partially or wholly, of such compound to RNA thatencodes ANGPTL3 ( which will be [COMPANY] Product - Specific Patent Rights ), or ( b ) claimingformulation technology or delivery devices ( other than methods of synthesizing or analyzingConjugate Technology ) . The [COMPANY] Manufacturing Patent Rights as of the Execution Date areset forth on Schedule 1.14 attached hereto